Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort StudyRobert Zangerle, Giota Touloumi, Josiane Warszawski et al.|Clinical Infectious Diseases|2017Cited by 63
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Christoph Stephan, Marguerite Guiguet et al.|Clinical Infectious Diseases|2020Cited by 45
Sex Differences in Overall and Cause-Specific Mortality among HIV-Infected Adults on Antiretroviral Therapy in Europe, Canada and the USInmaculada Jarrín, Julia del Amo, Markus Bickel et al.|Antiviral Therapy|2014Cited by 28
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHEREAndrew Atkinson, Luis Prieto, Marcel Zwahlen et al.|Clinical Infectious Diseases|2020Cited by 21